The FEI has today announced six adverse analytical findings involving prohibited substances.The cases involve the use of *Banned Substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).The athletes have been provisionally suspended from the date of notification (5 April 2017) until the FEI Tribunal renders its decision, and the horses have been provisionally suspended for two months:
Horse: Luke Skywalker 46 (FEI ID 46 /103XB94/USA)
Person Responsible: Paige Johnson (FEI ID 10013411/USA)
Event: CSI2* Wellington FL (USA), 17-22.01.2017
Prohibited Substance: Pramoxine
Horse: El Mate (FEI ID 104XI43/URU)
Person Responsible: Victoria Goñi (FEI ID 10042167/URU)
Event: CEI2* 120km Trinidad (URU), 3-5.02.2017
Prohibited Substance: Ergonovine
Horse: Sirene de la Motte (FEI ID 103RA62/BEL)
Person Responsible: Marlon Modolo Zanotelli (FEI ID 10031717/BRA)
Event: CSI3* Vilamoura (POR), 20-26.02.2017
Prohibited Substance: Sparteine
Horse: Horizon (FEI ID 105FJ02/USA)
Person Responsible: Adrienne Lyle (FEI ID 10015662/USA)
Event: CDI3* Wellington FL (USA), 8-12.02.2017
Prohibited Substance: Ractopamine
Horse: Don Principe (FEI ID USA41197/USA)
Person Responsible: Kaitlin Blythe (FEI ID 10046212/USA)
Event: CDIU25 Wellington FL (USA), 8-12.02.2017
Prohibited Substance: Ractopamine
Horse: Cenerado (FEI ID 104FU71/ITA)
Person Responsible: Giacomo Bassi (FEI ID 10035513/ITA)
Event: CSI3* Gorla Minore (ITA), 9-12.03.2017
Prohibited Substance: Stanozolol, Ketoprofen
Details on these cases can be found here and here. Information on the substances is available on the searchable FEI Equine Prohibited Substances Database.